I'm growing in the spikes
Release time:
2020-08-14
I have been in the peak growth
for two years. Over the past two years, the tolerance, support and help of the company's leaders, and the friendship, cooperation and mutual assistance among colleagues have given me confidence and a sense of sureness in my work. This is a precious experience in my life.
When I first arrived at Jinxi Factory, I happened to catch up with the installation of the air distribution machine of the production line in the powder needle workshop. For the first time, I saw Bosch production equipment imported from Germany. I was a little curious: what is the difference between German equipment and domestic equipment? It was not until I saw the various components on the sub-machine that I suddenly realized that small components, after a simple combination like building blocks, became large components, during which I could not see a single screw. This makes people have to sigh the precision of German equipment, and it is no wonder that it will become a must-see "scenic spot" for guests to visit since then ". After the certification of
airflow line, I was assigned to work at the water station. At first, I thought that the water station was a peripheral job and could not be linked to my ideals, but after working for a few months, my thoughts changed. The quality of purified water and water for injection determines the quality of the product. A small water station, like a human heart, provides fresh "blood" for the entire workshop; the external air-conditioning system, also like a human lung, provides clean air for the interior of the workshop. In this position, I learned the structure and usage of purified water machine, injection water machine, steam generator and other equipment, which greatly improved my ability.
2016 3 , I came to the granulation position of solid preparations and finally got my wish to come to the front line of pharmaceutical production. Compared with the water station, the granulation post is extremely hard, with large dust and heavy physical work. But after a period of work, I gradually found that this is also an extremely important position. The so-called granulation is to fully mix the raw and auxiliary materials of drugs into granules, that is, the intermediate before tabletting. This is the beginning of the production process of solid preparations. Once problems occur, it will lead to the stagnation of the entire production line and cause great Economic loss. And this "problem" is likely to be a small difference in moisture content. I admire my masters, they always work hard, with a hundred percent sense of responsibility, full of sweat to face the daily work, but also silently bear the trouble I this novice, carefully teach me the essentials of operation, precautions ......
After a year of rotation, I returned to the initial internship place- QA a. It is a pity that most of the familiar faces during the internship have been changed. Although I have the "experience" of internship, I didn't realize my knowledge of work until I was on the dripping pill line QA . However, fortunately, sister Lang Minxiao, the master, took me, the rookie, to start a new journey. After a while, I found that QA is not just about supervising daily work, but more about communication and coordination. The relationship between QC , QA and workshop production positions is closely linked and affects each other. Any problem in any link will affect the final product quality. Therefore, communication in the process is very important. Especially when verification is to be done, the workshop should take samples in time, and the QC side should coordinate the testing time and do a good job of communication. What impressed me most was the annual review report that began at the end of 11 . It took a whole month to summarize the quality indicators of products for a whole year and sort out the trend of product quality.
Due to the need of work, I took the position of QA in solid preparation this year. I am still familiar with the environment and equipment. From a different perspective, I have seen more new things. Thanks to the good relationship between teachers and friends with all the teachers during the rotation here, I can communicate smoothly and do many things easily.
The short two years are the two years of my life role conversion and the two years of my rapid growth. But this is just the beginning. With the gradual understanding of work, I found that my ability is far from enough, and there are still many places to learn and improve. I really appreciate my colleagues, teachers and leaders for their guidance and teaching. The journey in the future is still very long. I believe that in the big family of the peak, I can learn more. I also hope that I can quickly improve myself, realize my own value, and create more for the peak. (Zheng Nan)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31